Dr. Claude Piché
Dr. Claude Piché is a co-founder and the President and CEO of Locemia Solutions. At Locemia, Claude led the creation and development of Baqsimi, a needle-free rescue treatment for severe hypoglycemia; the product has since been launched world-wide by Eli Lilly. Prior to forming Locemia, Claude worked at private, public, and start-up biopharmaceutical companies with hands-on experience in research, regulatory affairs, marketing, operations and business development.
Claude is an active investor in several diabetes companies and serves as an advisor to many biopharmaceutical start-ups. He serves on the board for four privately held companies, two of which are developing diabetes-related products and one is a telemedicine company.
He holds degrees from the University of Saskatchewan (DVM) and the University of Calgary (MSc). He is the author or co-author of over 30 peer-reviewed scientific publications and over 40 scientific abstracts and presentations.
Claude is thrilled to be a part of Cecelia Health as he is enthusiastic about Cecelia’s unique approach of using technology to scale high-touch personal clinical care for patients dealing with chronic diseases such as diabetes. He believes Cecelia’s approach has the potential to dramatically improve access to care and clinical outcomes.